Supporting Informed Decision Making About Multi-cancer Early Detection Testing

Last updated: March 25, 2025
Sponsor: M.D. Anderson Cancer Center
Overall Status: Active - Recruiting

Phase

N/A

Condition

N/A

Treatment

Multi-cancer Early Detection

Multi-cancer Early Detection

Clinical Study ID

NCT06870916
2024-1925
NCI-2025-01726
  • Ages > 21
  • All Genders

Study Summary

To develop a new participant educational aid that can be used by participants to support informed decision-making about Multi-Cancer Early Detection (MCED) tests, which are new blood-based screening tests.

Eligibility Criteria

Inclusion

Inclusion Criteria:

• Recruitment and eligibility will be assessed by CCETR.CCETR staff will help distribute recruitment flyers, assess subject eligibility, and refer eligible subjects to the research team (Appendix B, C & I).

Exclusion

Exclusion Criteria:

• History of cancer other than basil cell and squamous cell skin cancer, per self-report.

Study Design

Total Participants: 150
Treatment Group(s): 2
Primary Treatment: Multi-cancer Early Detection
Phase:
Study Start date:
March 07, 2025
Estimated Completion Date:
January 01, 2027

Study Description

To develop a prototype participant educational aid that can be used by participants to support informed decision making about MCED testing. The aims of the pilot project include the following:

  1. Conduct focus groups to explore preferences and concerns about MCED testing among adults of screening age.

  2. Based on salient themes from focus group discussion, develop and administer surveys to explore preferences and concerns about MCED testing among adults of screening age.

  3. Using findings from the focus groups and surveys, develop prototype patient educational aids about MCED testing following a user-centered design strategy.

Connect with a study center

  • MD Anderson Cancer Center

    Houston, Texas 77030
    United States

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.